FLGT
Fulgent Genetics Inc
22.20$
+3.0%
vs. previous close
Closing price · As of: Sep 25, 2026
Statements
Cash Flow
All figures as the change versus the prior period, in percent. Periods without a positive comparison base stay empty.
Tick rows to compare them in a chart (up to 4)
| Line item | Q3 23 | Q4 23 | Q1 24 | Q2 24 | Q3 24 | Q4 24 | Q1 25 | Q2 25 | Q3 25 | Q4 25 | Q1 26 | Q2 26 | LTM* |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| – | +45.8% | -51.3% | -41.0% | -461.9% | – | -117.7% | – | – | -803.5% | – | -434.8% | – | |
| – | +1.8% | +2.0% | -7.7% | -3.8% | +4.6% | -4.4% | +2.3% | -0.3% | +1.2% | -1.8% | +0.7% | – | |
| – | +4.9% | +0.8% | +1.0% | -6.1% | -4.7% | +1.4% | -4.8% | -3.2% | -4.5% | +6.6% | +87.2% | – | |
| – | – | -52.0% | -152.6% | – | – | -160.5% | – | – | -3,108.0% | – | -193.3% | – | |
| – | -36.9% | +30.6% | +219.1% | +50.9% | -80.7% | +24.9% | +44.7% | -11.4% | -17.7% | +4.5% | -25.8% | – | |
| – | +20.9% | -294.4% | – | +23.0% | -405.6% | – | +92.6% | -64.3% | -41.6% | -1.9% | +364.4% | – | |
| – | +783.1% | -92.0% | -71.5% | -20.8% | -43.9% | +4,266.1% | -75.9% | -86.0% | +25.2% | +8,866.0% | -40.6% | – | |
| – | – | – | – | – | +0.0% | +345.6% | -85.5% | +0.0% | +0.0% | +540.9% | -84.4% | – | |
| – | +480.0% | -89.2% | -59.2% | -50.5% | -42.3% | +3,316.5% | -76.4% | -83.1% | +20.0% | +8,295.7% | -46.0% | – | |
| – | -47.9% | -419.4% | – | -166.5% | – | – | +69.7% | +44.5% | -326.6% | – | – | – | |
| – | +122.4% | -72.9% | -369.8% | – | – | -143.1% | – | – | -1,743.7% | – | -1,557.3% | – |
LTM = last twelve months (sum of the four most recent quarters).
Data as of: September 25, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)
Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.